BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 29307570)

  • 21. Identification of a novel Ras-regulated proapoptotic pathway.
    Khokhlatchev A; Rabizadeh S; Xavier R; Nedwidek M; Chen T; Zhang XF; Seed B; Avruch J
    Curr Biol; 2002 Feb; 12(4):253-65. PubMed ID: 11864565
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Signal-transducing protein phosphorylation cascades mediated by Ras/Rho proteins in the mammalian cell: the potential for multiplex signalling.
    Denhardt DT
    Biochem J; 1996 Sep; 318 ( Pt 3)(Pt 3):729-47. PubMed ID: 8836113
    [TBL] [Abstract][Full Text] [Related]  

  • 23. K-Ras protein as a drug target.
    McCormick F
    J Mol Med (Berl); 2016 Mar; 94(3):253-8. PubMed ID: 26960760
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structural evidence for feedback activation by Ras.GTP of the Ras-specific nucleotide exchange factor SOS.
    Margarit SM; Sondermann H; Hall BE; Nagar B; Hoelz A; Pirruccello M; Bar-Sagi D; Kuriyan J
    Cell; 2003 Mar; 112(5):685-95. PubMed ID: 12628188
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fragment-based drug discovery of triazole inhibitors to block PDEδ-RAS protein-protein interaction.
    Chen D; Chen Y; Lian F; Chen L; Li Y; Cao D; Wang X; Chen L; Li J; Meng T; Huang M; Geng M; Shen J; Zhang N; Xiong B
    Eur J Med Chem; 2019 Feb; 163():597-609. PubMed ID: 30562696
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ras signalling. Caught in the act of the switch-on.
    Wittinghofer F
    Nature; 1998 Jul; 394(6691):317, 319-20. PubMed ID: 9690464
    [No Abstract]   [Full Text] [Related]  

  • 27. The structural basis of the activation of Ras by Sos.
    Boriack-Sjodin PA; Margarit SM; Bar-Sagi D; Kuriyan J
    Nature; 1998 Jul; 394(6691):337-43. PubMed ID: 9690470
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rad and Rem are non-canonical G-proteins with respect to the regulatory role of guanine nucleotide binding in Ca(V)1.2 channel regulation.
    Chang DD; Colecraft HM
    J Physiol; 2015 Dec; 593(23):5075-90. PubMed ID: 26426338
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Direct Inhibitors of Ras-Effector Protein Interactions.
    Upadhyaya P; Bedewy W; Pei D
    Mini Rev Med Chem; 2016; 16(5):376-82. PubMed ID: 26423701
    [TBL] [Abstract][Full Text] [Related]  

  • 30. RAS/Effector Interactions from Structural and Biophysical Perspective.
    Erijman A; Shifman JM
    Mini Rev Med Chem; 2016; 16(5):370-5. PubMed ID: 26423700
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Current status of the development of Ras inhibitors.
    Shima F; Matsumoto S; Yoshikawa Y; Kawamura T; Isa M; Kataoka T
    J Biochem; 2015 Aug; 158(2):91-9. PubMed ID: 26100833
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High affinity IgG receptor activation of Src family kinases is required for modulation of the Shc-Grb2-Sos complex and the downstream activation of the nicotinamide adenine dinucleotide phosphate (reduced) oxidase.
    Park RK; Erdreich-Epstein A; Liu M; Izadi KD; Durden DL
    J Immunol; 1999 Dec; 163(11):6023-34. PubMed ID: 10570290
    [TBL] [Abstract][Full Text] [Related]  

  • 33. RalGDS family members couple Ras to Ral signalling and that's not all.
    Ferro E; Trabalzini L
    Cell Signal; 2010 Dec; 22(12):1804-10. PubMed ID: 20478380
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Challenges in Ras therapeutics in pancreatic cancer.
    Choi M; Bien H; Mofunanya A; Powers S
    Semin Cancer Biol; 2019 Feb; 54():101-108. PubMed ID: 29170065
    [TBL] [Abstract][Full Text] [Related]  

  • 35. RGK family G-domain:GTP analog complex structures and nucleotide-binding properties.
    Sasson Y; Navon-Perry L; Huppert D; Hirsch JA
    J Mol Biol; 2011 Oct; 413(2):372-89. PubMed ID: 21903096
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The many faces of Ras: recognition of small GTP-binding proteins.
    Corbett KD; Alber T
    Trends Biochem Sci; 2001 Dec; 26(12):710-6. PubMed ID: 11738594
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibody targeting intracellular oncogenic Ras mutants exerts anti-tumour effects after systemic administration.
    Shin SM; Choi DK; Jung K; Bae J; Kim JS; Park SW; Song KH; Kim YS
    Nat Commun; 2017 May; 8():15090. PubMed ID: 28489072
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activation of the small GTP-binding protein Ras in the heart by hypertrophic agonists.
    Sugden PH; Clerk A
    Trends Cardiovasc Med; 2000 Jan; 10(1):1-8. PubMed ID: 11150721
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Specificity of inhibition of ras-p21 signal transduction by peptides from GTPase activating protein (GAP) and the son-of sevenless (SOS) ras-specific guanine nucleotide exchange protein.
    Chie L; Chung D; Pincus MR
    Protein J; 2005 May; 24(4):253-8. PubMed ID: 16283548
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The RAS-Effector Interface: Isoform-Specific Differences in the Effector Binding Regions.
    Nakhaeizadeh H; Amin E; Nakhaei-Rad S; Dvorsky R; Ahmadian MR
    PLoS One; 2016; 11(12):e0167145. PubMed ID: 27936046
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.